Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites

Autor: Agnandji, ST, Lell, B, Fernandes, JF, Abossolo, BP, Kabwende, AL, Adegnika, AA, Mordmueller, B, Issifou, S, Kremsner, PG, Loembe, MM, Sacarlal, J, Aide, P, Madrid, L, Lanaspa, M, Mandjate, S, Aponte, JJ, Bulo, H, Nhama, A, Macete, E, Alonso, P, Abdulla, S, Salim, N, Mtoro, AT, Mutani, P, Tanner, M, Mavere, C, Mwangoka, G, Lweno, O, Juma, OA, Shekalaghe, S, Tinto, H, D'Alessandro, U, Sorgho, H, Valea, I, Ouedraogo, JB, Lompo, P, Diallo, S, Traore, O, Bassole, A, Dao, E, Hamel, MJ, Kariuki, S, Oneko, M, Odero, C, Otieno, K, Awino, N, Muturi-Kioi, V, Omoto, J, Laserson, KF, Slutsker, L, Otieno, W, Otieno, L, Otsyula, N, Gondi, S, Otieno, A, Ogutu, B, Ochola, J, Onyango, I, Oyieko, J, Njuguna, P, Chilengi, R, Akoo, P, Kerubo, C, Maingi, C, Olotu, A, Bejon, P, Marsh, K, Mwabingu, G, Gitaka, J, Owusu-Agyei, S, Asante, KP, Boahen, O, Dosoo, D, Adjei, G, Adeniji, E, Yawson, AK, Kayan, K, Chandramohan, D, Greenwood, B, Lusingu, J, Gesase, S, Malabeja, A, Abdul, O, Mahende, C, Liheluka, E, Lemnge, M, Theander, TG, Drakeley, C, Mbwana, J, Ansong, D, Agbenyega, T, Adjei, S, Boateng, HO, Rettig, T, Bawa, J, Sylverken, J, Sambian, D, Sarfo, A, Agyekum, A, Martinson, F, Hoffman, I, Mvalo, T, Kamthunzi, P, Nkomo, R, Tembo, T, Tsidya, GTM, Kilembe, J, Chawinga, C, Ballou, WR, Cohen, J, Guerra, Y, Jongert, E, Lapierre, D, Leach, A, Lievens, M, Ofori-Anyinam, O, Olivier, A, Vekemans, J, Kaslow, D, Leboulleux, D, Savarese, B, Schellenberg, D, Partnership, RTSSCT

Publikováno v: PLoS Medicine
PLoS Medicine, Vol 11, Iss 7, p e1001685 (2014)

Mary Hamel and colleagues in the RTS,S Clinical Trials Partnership report updated safety and efficacy results from an ongoing Phase 3 trial, including calculations of vaccine impact (malaria cases prevented). Please see later in the article for the E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6236e8cf4d7a1ce20ddc0ba7bb18b40
http://europepmc.org/articles/PMC4114488

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ebola vaccines for mass immunisation in affected regions.

Autor: Agnandji ST; Centre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany; Fondation pour la Recherche Scientifique, Cotonou, Bénin. Electronic address: agnandjis@cermel.org., Loembe MM; Africa Centers for Disease Control and Prevention, Adis-Abeba, Ethiopia.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jan; Vol. 22 (1), pp. 8-10. Date of Electronic Publication: 2021 Sep 13.

COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.

Autor: Inzaule SC; Africa Centres for Disease Control and Prevention, African Union Headquarters, Addis Ababa, Ethiopia., Ondoa P; African Society for Laboratory Medicine, Addis Ababa, Ethiopia., Loembe MM; Africa Centres for Disease Control and Prevention, African Union Headquarters, Addis Ababa, Ethiopia., Tebeje YK; Africa Centres for Disease Control and Prevention, African Union Headquarters, Addis Ababa, Ethiopia., Ouma AEO; Africa Centres for Disease Control and Prevention, African Union Headquarters, Addis Ababa, Ethiopia., Nkengasong JN; Africa Centres for Disease Control and Prevention, African Union Headquarters, Addis Ababa, Ethiopia.

Publikováno v: PLoS medicine [PLoS Med] 2021 Jun 23; Vol. 18 (6), pp. e1003666. Date of Electronic Publication: 2021 Jun 23 (Print Publication: 2021).

First evidence for continuous circulation of hepatitis A virus subgenotype IIA in Central Africa.

Autor: Abe H; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan., Ushijima Y; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan., Bikangui R; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany., Ondo GN; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., Zadeh VR; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Pemba CM; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Mpingabo PI; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Igasaki Y; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan., de Vries SG; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Division of Internal Medicine, Department of Infectious Diseases, Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands., Grobusch MP; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.; Division of Internal Medicine, Department of Infectious Diseases, Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands., Loembe MM; Université des Sciences de la Santé de Libreville, Libreville, Gabon., Agnandji ST; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany., Lell B; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria., Yasuda J; Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.; Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.; National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Nagasaki, Japan.

Publikováno v: Journal of viral hepatitis [J Viral Hepat] 2020 Nov; Vol. 27 (11), pp. 1234-1242. Date of Electronic Publication: 2020 Jun 29.